Crossref
Should we vaccinate against long-COVID?
Vaccine Insights · 2022
DOI: 10.18609/vac.2022.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccine Insights, 2022. Verfasst von Peter Hotez und 17 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hotez, P., Batista, C., Amor, Y. B., Ergonul, O., Figueroa, P., Gursel, M., Hassanain, M., Kang, G., Kaslow, D. C., Kim, J. H., Lall, B., Larson, H., Sheahan, T., Shoham, S., Wilder-Smith, A., Sow, S. O., Yadav, P., & Bottazzi, M. E. (2022). Should we vaccinate against long-COVID?. Vaccine Insights. https://doi.org/10.18609/vac.2022.016
Vancouver
Hotez P, Batista C, Amor YB, Ergonul O, Figueroa P, Gursel M, et al. Should we vaccinate against long-COVID?. Vaccine Insights. 2022. doi:10.18609/vac.2022.016
BibTeX
@article{Hotez2022,
author = {Hotez, Peter and Batista, Carolina and Amor, Yanis Ben and Ergonul, Onder and Figueroa, Peter and Gursel, Mayda and Hassanain, Mazen and Kang, Gagandeep and Kaslow, David C. and Kim, Jerome H. and Lall, Bhavna and Larson, Heidi and Sheahan, Timothy and Shoham, Shmuel and Wilder-Smith, Annelies and Sow, Samba O and Yadav, Prashant and Bottazzi, Maria Elena},
title = {Should we vaccinate against long-COVID?},
journal = {Vaccine Insights},
year = {2022},
doi = {10.18609/vac.2022.016}
}
EUVIMED